Get the Stockscreener App
2.71
2.52%
-0.07
Pre-market:
2.73
0.02
+0.74%
Neuraxis Inc stock is traded at $2.71, with a volume of 38,084.
It is down -2.52% in the last 24 hours and up +6.69% over the past month.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
See More
Previous Close:
$2.78
Open:
$2.78
24h Volume:
38,084
Relative Volume:
0.10
Market Cap:
$28.87M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-3.3598
EPS:
-0.8066
Net Cash Flow:
-
1W Performance:
+1.50%
1M Performance:
+6.69%
6M Performance:
+0.74%
1Y Performance:
-11.73%
1-Day Range:
$2.71
$2.82
1-Week Range:
$2.645
$2.8299
52-Week Range:
$1.33
$6.20
Neuraxis Inc Stock (NRXS) Company Profile
Name
Neuraxis Inc
Sector
Industry
Phone
(812) 689-0791
Address
11550 North Meridian Street, Suite 325, Carmel
Compare NRXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
2.71 | 29.61M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neuraxis Inc Stock (NRXS) Latest News
Is Neuraxis Inc. stock a defensive play amid uncertaintyJuly 2025 Gainers & Technical Entry and Exit Tips - Newser
Is Neuraxis Inc. stock good for wealth creationQuarterly Profit Review & Low Drawdown Investment Ideas - Newser
How supply shortages influence Neuraxis Inc. stock2025 Support & Resistance & High Yield Stock Recommendations - Newser
Is Neuraxis Inc. stock undervalued after correctionJuly 2025 Gainers & Safe Entry Trade Signal Reports - Newser
Neuraxis secures VA Federal Supply Schedule contract - MSN
What dividend safety rating applies to Neuraxis Inc. stockJuly 2025 Retail & AI Based Buy/Sell Signal Reports - Newser
Neuraxis secures veterans affairs federal supply schedule contract, broadening access to more patients with functional abdominal pain - MarketScreener
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain - The Manila Times
NeurAxis (NYSE American: NRXS) lands VA FSS deal, opening path to nearly 7M veterans - Stock Titan
NeurAxis, Inc. (NRXS) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
How NeurAxis Inc. stock reacts to global recession fearsBond Market & Community Verified Trade Signals - moha.gov.vn
Can NeurAxis Inc. stock double in next 5 yearsJuly 2025 Summary & Trade Opportunity Analysis - BỘ NỘI VỤ
NeurAxis Expands Stock Offering to $6.27 Million - MSN
What analysts say about NeurAxis Inc stockMACD Trading Signals & Today’s Picks, Tomorrow’s Winners - earlytimes.in
Why Neuraxis Inc. stock is trending on social mediaSwing Trade & Safe Entry Point Alerts - newser.com
Published on: 2025-11-20 05:27:18 - newser.com
Is NeurAxis Inc. stock attractive for long term wealth buildingTrade Analysis Report & Verified Stock Trade Ideas - newser.com
Can NeurAxis Inc. stock hit analyst price targetsEarnings Risk Report & Community Verified Trade Alerts - newser.com
Using Ichimoku Cloud for NeurAxis Inc. technicals2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth - MSN
Why Neuraxis Inc. stock is favored by hedge funds2025 Geopolitical Influence & Proven Capital Preservation Methods - newser.com
Will NeurAxis Inc. continue its uptrendWeekly Volume Report & Safe Entry Point Alerts - newser.com
Using data models to predict NeurAxis Inc. stock movementEarnings Risk Summary & Real-Time Chart Breakout Alerts - newser.com
NeurAxis, Inc. (NASDAQ:NRXS) Q4 2024 Earnings Call Transcript - MSN
Risk vs reward if holding onto NeurAxis Inc.Earnings Performance Report & Stepwise Entry and Exit Trade Signals - newser.com
What to do if you’re stuck in NeurAxis Inc.July 2025 Breakouts & Real-Time Market Trend Scan - newser.com
NeurAxis, Inc. Earnings Call: Growth Amid Challenges - MSN
Neuraxis announces new medical policy coverage in Michigan - MSN
Can Neuraxis Inc. stock hold up in economic slowdown2025 Market Trends & High Accuracy Swing Entry Alerts - newser.com
Neuraxis Inc Stock (NRXS) Financials Data
There is no financial data for Neuraxis Inc (NRXS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Cap:
|
Volume (24h):